Nazrul Islam
7 Papers
1 Citations
Nazrul Islam is an academic researcher. The author has contributed to research in topics: Internal medicine & Adverse effect. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Liposomal drug delivery strategies to eradicate bacterial biofilms: Challenges, recent advances, and future perspectives.
TL;DR: Antimicrobial-loaded liposomal nanoparticles show improved antibiotic delivery and eradication of biofilm-related infections, with enhanced antibacterial and anti-biofilm activities compared to free drugs, offering a promising strategy to address antibiotic resistance and recurrent infections.
9
Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
Nazrul Islam,David Reid +1 more
TL;DR: Inhaled antibiotics, particularly liposomal-packaged formulations, offer a promising strategy for treating lower respiratory tract infections caused by antibiotic-resistant biofilm-dwelling bacteria, with improved efficacy and reduced systemic adverse effects.
5
Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives
TL;DR: Antibiotic-loaded inhalable liposomal nanoparticles (ALILNPs) show promise in treating lower respiratory tract infections by directly delivering antibiotics to infected lung cells, enhancing efficacy and reducing antimicrobial resistance, with potential for sustained lung function improvements.
4
Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation
TL;DR: In this article , the benefits of inhaled drug delivery, including rapid onset of action and very low doses to achieve therapeutic efficacy, were discussed for the management of atrial fibrillation.
Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives
TL;DR: Ciprofloxacin-loaded inhalable formulations against LRTIs offer promising treatment options but face challenges in effectiveness and resistance. Recent advances include well-tolerated DPI formulations and the potential use of phage PEV20 and fatty acid biomarkers. Further research is needed to address unresolved issues and evaluate their effectiveness in bronchiectasis and COPD.
2